助剂trastuzumab的20周年纪念:对突破性时刻的反思
G Gentile1, R Gerosa2, E de Azambuja3
1Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Bruxelles, Belgium; Department of Radiological, Oncological and Pathological Science, School of Medicine and Dentistry, Sapienza University of Rome, Italy.
概括
特拉斯图祖马布是HER2阳性早期乳腺癌的重要治疗方法,可提供持久的生存益处,心脏毒性可控. 它的持续相关性得到了新配方和生物类似药的支持.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 特拉斯图祖马布是治疗HER2阳性早期乳腺癌 (eBC) 的关键疗法.
- 长期数据证实了它在患者群体中具有显著和持久的生存益处.
- 特拉斯图祖马布诱导的心脏毒性 (TIC) 是罕见的,可控的.
研究的目的:
- 审查trastuzumab在HER2阳性eBC中的持久疗效和安全性.
- 讨论特斯图祖马布治疗的进展和挑战.
- 评估其在不断变化的治疗景观中的未来作用.
主要方法:
- 从关键辅助剂试验中分析长期随访数据.
- 对支持有效性和安全性的现实世界证据的审查.
- 评估新兴生物标志物和心脏保护策略.
主要成果:
- 特拉斯图祖马布在HER2+ eBC中提供了持久的生存改善.
- TIC的发病率很低,尤其是没有先前接触过 antracycline 的情况下.
- 皮下配方和生物仿制药提高了可访问性和方便性.
结论:
- 特拉斯图祖马布仍然是HER2阳性eBC的基石,提供了经过证明的长期益处.
- 除了HER2状态之外,没有经过验证的预测生物标志物存在,尽管研究仍在进行中.
- 尽管有新的药物,但特斯图祖马布可能仍然是关键的治疗方法,特别是在低风险患者中.
更多相关视频
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.5K
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
3.7K
相关概念视频
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
02:50Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
01:30Cancer Vaccines
929
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
929